Welcome to ETOP IBCSG Partners Foundation
As of July 1, 2021, the two highly respected clinical and translational cancer research foundations ETOP (European Thoracic Oncology Platform) and IBCSG (International Breast Cancer Study Group) have merged to form the joint entity ETOP IBCSG Partners Foundation.
The new foundation brings together two strong and equal partners which collectively have a global reach for the conduct of collaborative projects in Europe, North and South America, Asia, Africa and Australia. By joining forces, the position as an international academic research organization is further strengthened.
ETOP IBCSG Partners Foundation will pursue and maintain the leading scientific research in thoracic malignancies and breast cancer and will also be open to promote and conduct international clinical research on other topics.
The collaboration with the Coordinating Center in Berne as well as with the Frontier Science Foundation in Greece and the USA will continue to provide and encompass all expertise needed to develop and coordinate clinical and translational cancer research on an international level.
About us
History and Background
ETOP, founded 2009, had become one of the leading European organizations performing international clinical and translational research in thoracic malignancies and was initiated in response to concerns raised by European lung cancer investigators, expressing the need to better promote and conduct academic clinical research across borders in Europe. The group structure was built on the model of the International Breast Cancer Study Group. ETOP, a not-for-profit foundation was able to draw on the expertise and support of the IBCSG Coordinating Center in Berne.
IBCSG was formed in 1977 as the “Ludwig Breast Cancer Study Group”. When the Ludwig Institute of Cancer Research decided in 1985 to focus on laboratory research, the Group continued with a new name and structure - the International Breast Cancer Study Group (IBCSG). It was legally established as a not-for-profit foundation in 1992. IBCSG and its investigators are renowned for their clinical and translational research in breast cancer. In particular, the group pioneered the research in combined hormone- and chemotherapy, timing and duration of adjuvant therapies, as well as improvement of quality of life. IBCSG stands for a number of practice-changing studies in the breast cancer field.
The legal seat of both foundations was Berne, Switzerland.
ETOP IBCSG Partners Foundation
ETOP IBCSG Partners Foundation brings together two of the leading recognized and reputable innovators in clinical and translational cancer research, strengthening the position as an international academic research organization through broadened competency, synergy, sustainability as well as the reduction of overhead.
Both partners share matching missions and top-level scientific objectives which secure the future success as well as the vision of expansion, both geographically and with regard to the research area.
Foundation Board
ETOP IBCSG Partners Foundation Foundation Board Members
Rolf Stahel, President
Coordinating Center, Effingerstrasse 33,
3008 Bern, Switzerland
This email address is being protected from spambots. You need JavaScript enabled to view it.
Stefan Aebi
Member
Switzerland
Paul Baas
Member
Netherlands
Marco Colleoni
Member
Italy
Richard Gelber
Member
USA
Sherene Loi
Member
Australia
Keith McGregor
Member
Switzerland
Solange Peters
Member
Switzerland
Sanjay Popat
Member
UK
Rafael Rosell
Member
Spain
Scientific Committees
The Scientific Committees support and advise the Foundation Board actively on all scientific matters relating to the purpose and the activities of the Foundation. Their tasks particularly include the initiation, evaluation, planning, and monitoring of clinical studies and translational projects.
ETOP IBCSG Partners Foundation Scientific Committee Breast Members
Marco Colleoni
Co-Chair
Italy
Sherene Loi
Co-Chair
Australia
Philippe Aftimos
Vice Co-Chair
Belgium
Elisabetta Munzone
Vice Co-Chair
Italy
Frances Boyle
Member
Australia
Giuseppe Curigliano
Member
Italy
Peter Dubsky
Member
Switzerland
Günther Gruber
Member
Switzerland
Per Karlsson
Member
Sweden
Giuseppe Viale
Member
Italy
Meredith Regan
Member
USA
Alan Coates
Guest
Australia
Anita Hiltbrunner
Guest
Switzerland
Elisabet Öhrn
Guest
Sweden
Heidi Roschitzki
Guest
Switzerland
Translational Research Working Group (Breast) Members
Giuseppe Viale
Chair
Italy
Cathrin Brisken
Member
Switzerland
Silvana Canevari
Member
Italy
Rosita Kammler
Secretary
Switzerland
Brian Leyland-Jones
Member
United States
Salvatore Pece
Member
Italy
Meredith Regan
Member
United States
Christos Sotiriou
Member
Belgium
Beat Thürlimann
Member
Switzerland
ETOP IBCSG Partners Foundation Scientific Committee Thoracic Members
Solange Peters
Chair
Switzerland
Ourania Dafni
Member
Greece
Rafal Dziadziuszko
Member
Poland
Enriqueta Felip
Member
Spain
Stephen Finn
Chair TRWG
Ireland
Suresh Senan
Member
Netherlands
Egbert Smit
Member
Netherlands
Ross Soo
Member
Singapore
Jean Yannis Perentes
Member
Switzerland
Maurice Pérol
Member
Switzerland
Walter Weder
Member
Switzerland
Anne-Marie Baird
Guest
Ireland
Byoung Chul Cho
Guest
South Korea
Nick Pavlakis
Guest
Australia
Ben Solomon
Guest
Australia
Translational Research Working Group (Thoracic) Members
Coordinating Center
The Coordinating Center (CC) situated in Berne, Switzerland is the headquarters of ETOP IBCSG Partners Foundation.
We provide high quality support and prime operational know-how for all aspects of clinical trial conduct and translational research. Through close cooperation with our vast academic network and partners, we aim to facilitate collaboration in the field of clinical and translational cancer research.
Our CC team is responsible for both the overall coordination as well as for specialized tasks such as: Safety and Regulatory, Pharmacovigilance, Drug Supply, Medical Expertise, Translational Research coordination, Qualify of Life, Monitoring, Quality Assurance and Audits, Program for Young Patients and Group Administration. For thoracic trials, we also maintain Project and Data Management.
In addition, ETOP IBCSG Partners Foundation benefits from the proficiency of the Frontier Science Foundation in Greece and the U.S. to bring together all the expertise needed in order to develop and coordinate clinical and translational research at the international level.
ETOP IBCSG Partners Foundation Coordinating Center Staff
Anita Hiltbrunner
Director
This email address is being protected from spambots. You need JavaScript enabled to view it.
Heidi Roschitzki-Voser
Head Trial Activities / Deputy Director
This email address is being protected from spambots. You need JavaScript enabled to view it.
Hafeezul Adnan
Clinical Data Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Manuela Akaltan
Clinical Data Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Sabin Allemann
Scientific Collaborator SRO / Drug Supply Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Kathleen Beese
Executive Officer
This email address is being protected from spambots. You need JavaScript enabled to view it.
Marcel Berglas
IT Specialist
This email address is being protected from spambots. You need JavaScript enabled to view it.
Isabel Campus
Coworker Finance Department
This email address is being protected from spambots. You need JavaScript enabled to view it.
Miriam Christoffel
Project Manager Translational Research Coordination
This email address is being protected from spambots. You need JavaScript enabled to view it.
Carmen Comune
CRA / Trial Monitor
This email address is being protected from spambots. You need JavaScript enabled to view it.
Nino Giacomelli
Scientific Administrator
This email address is being protected from spambots. You need JavaScript enabled to view it.
Adriana Gasca Ruchti
Medical Reviewer
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Sarah Hiltbrunner
Office Assistant
This email address is being protected from spambots. You need JavaScript enabled to view it.
Belén Hahn
CRA / Trial Monitor
This email address is being protected from spambots. You need JavaScript enabled to view it.
Leonard Hofmann
IT Specialist
This email address is being protected from spambots. You need JavaScript enabled to view it.
Rico Hunkeler
Clinical Trial Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Rosita Kammler
Head Translational Research Coordinator (TRC)
This email address is being protected from spambots. You need JavaScript enabled to view it.
Uli Kodjadjiku
Clinical Trial Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Marc Marbot
Coworker Administration Director
This email address is being protected from spambots. You need JavaScript enabled to view it.
Marijana Mathys
Head Finances
This email address is being protected from spambots. You need JavaScript enabled to view it.
Suganiya Nagarajan
Clinical Data Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Lionel Nobs
CRA / Trial Monitor
This email address is being protected from spambots. You need JavaScript enabled to view it.
Manuel Papparella
Junior CRA
This email address is being protected from spambots. You need JavaScript enabled to view it.
Mariana Pardo Contreras
CRA / Trial Monitor
This email address is being protected from spambots. You need JavaScript enabled to view it.
Taisia Polidori
Scientific Collaborator Safety and Regulatory
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Rita Pfister
Deputy Head Safety and Regulator Office
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Anne-Christine Piguet
Lead Clinical Data Management / Deputy Head Clinical Trial Management
This email address is being protected from spambots. You need JavaScript enabled to view it.
Sabrina Ribeli-Hofmann
Drug Supply Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Karin Ribi
Head Quality of Life Office
This email address is being protected from spambots. You need JavaScript enabled to view it.
Veronica Richina
CRA/Monitor
This email address is being protected from spambots. You need JavaScript enabled to view it.
Virginia Rodriguez-Martinez
Lead Clinical Trial Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Susanne Roux
Head Clinical Trial Management / Deputy Head Trial Activities
This email address is being protected from spambots. You need JavaScript enabled to view it.
Barbara Ruepp
Head Safety and Regulator
This email address is being protected from spambots. You need JavaScript enabled to view it.
Monica Ruggeri
Head Young Patient Programs / Auditor
This email address is being protected from spambots. You need JavaScript enabled to view it.
Elizabeth Rugiati
Project Manager Quality Assurance and Audit
This email address is being protected from spambots. You need JavaScript enabled to view it.
Magdalena Sánchez-Hohl
CRA / Trial Monitor
This email address is being protected from spambots. You need JavaScript enabled to view it.
Mirjam Schneider
Scientific Pharmacovigilance Collaborator SRO
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Judith Schroeder
Head Quality Assurance and Audit Office
This email address is being protected from spambots. You need JavaScript enabled to view it.
Robin Schweri
Clinical Trial Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Sandra Trösch
Scientific Collaborator SRO
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Karin Tschan
Clinical Data Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
Patrick Vagenknecht
Project Manager Translational Research Coordination
This email address is being protected from spambots. You need JavaScript enabled to view it.
Marianne Wenger
Head Human Ressources / Project Manager Meeting / Project Manager Communication
This email address is being protected from spambots. You need JavaScript enabled to view it.
Michael Wiedemann
Head Clinical Monitoring
This email address is being protected from spambots. You need JavaScript enabled to view it.
Isabel Zigomo
Medical Reviewer
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Daniela Züger
Drug Supply Manager
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Partners
Frontier Science Foundation-Hellas
Ourania Dafni
Member
Greece
Frontier Science Foundation-Hellas (FSF-H), serves as ETOP’s statistical center, since 2011. FSF-H, incorporated in Athens, Greece, is a non-profit research organization, aiming to promote statistics in oncology through collaborative research in clinical trials, education and training of health scientists. The Board of FSF-H includes recognized leaders in the field of Biostatistics, and is chaired by Professor Rich Gelber (Harvard School of Public Health). It was co-founded by the renowned Harvard Biostatistics Professors Marvin Zelen and Steve Lagakos, and is directed by Professor Urania Dafni (National and Kapodistrian University of Athens). The current statistical team consists of ten scientists holding post-graduate degrees in Biostatistics, and/or a Doctorate. Biostatistical expertise is provided from conception and design to dissemination of results, in all ETOP Clinical Trials as well as in translational research projects within the Lungscape and Mesoscape platforms.
Frontier Science and Technology Research Foundation
Meredith Regan
Member
United States
The IBCSG Statistical and Data Management Center (SDMC), is located at Frontier Science Technology and Research Foundation (FSTRF), Amherst, NY, USA, and the Dana-Farber Cancer Institute (DFCI) Department of Data Science, Boston, MA, USA.
Frontier Science is a not-for-profit organization founded in 1975 with an international reputation as an innovative and highly-capable data management and statistical organization, collaborating with research networks, pharmaceutical companies and others in the design, conduct and execution of clinical trials in cancer and other disease settings throughout the world. Frontier Science and statisticians at DFCI have closely collaborated since the founding of IBCSG in 1977.
The IBCSG SDMC oversees data collection, processing and management; documentation development; trial activation and coordination; technical support and training for Participating Centers/Cooperative Groups; statistical design and analysis; and scientific coordination of research dissemination.